Immunotherapy of advanced hepatocellular carcinoma: case report and literature review

Immunotherapy of advanced hepatocellular carcinoma: case report and literature review

Hepatocellular carcinoma is a common type of liver malignancy and one of the leading causes of cancer death worldwide. In the Russian Federation, according to statistical reports, there is also an increase in the incidence. For over 10 years, the tyrosine kinase inhibitor sorafenib has been the only...

Full description

Bibliographic Details
Main Authors: K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, R. R. Abdeev, N. I. Sultanbaeva, V. G. Nigmatullin, E. V. Popova
Format: Article
Language:Russian
Published: Remedium Group LLC 2022-06-01
Series:Медицинский совет
Subjects:
hepatocellular carcinoma
immunotherapy
atezolizumab
bevacizumab
checkpoint inhibitors
antiangiogenic therapy
Online Access:https://www.med-sovet.pro/jour/article/view/6912

Similar Items

Similar Items